Начало › Рак на яйчниците › Флорида › Miami
Клинични проучвания за Рак на яйчниците в Miami, FL
23 проучвания за Рак на яйчниците търсят участници в обекти в и около Miami (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Набиране на участнициНаблюдателно проучване
- Genoma Research, Inc., Miami
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Набиране на участнициФаза 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- Sylvester Comprehensive Cancer Center, Miami
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Набиране на участнициФаза 2
- Sylvester Comprehensive Cancer Center, Miami
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Набиране на участнициФаза 2
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Набиране на участнициФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- University of Miami, Miami
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Набиране на участнициФаза 3
- Mt. Sinai Comprehensive Cancer Center, Miami
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Набиране на участници
- Jackson Memorial Hospital-Holtz Children's Hospital, Miami
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Набиране на участнициФаза 4
- University of Miami, Miami
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Набиране на участнициФаза 2/3
- Sylvester Cancer Center, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набиране на участнициФаза 2
- University of Miami Hospital and Clinics, Miami
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
Набиране на участници
- University of Miami, Miami
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Набиране на участнициФаза 1/2
- University of Miami, Miami
- Biogenix, Miami
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Набиране на участнициФаза 1/2
- University of Miami Hospital and Clinics, Miami
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Набиране на участнициЗдравите доброволци са добре дошли
- Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine, Miami
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Набиране на участнициФаза 3
- University of Miami Hospital and Clinics, Miami
- Miami Cancer Institute, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Набиране на участници
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набиране на участнициФаза 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Miami Cancer Institute, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Miami
Проучвания за Рак на яйчниците в други градове
- Houston, TX89 проучвания
- New York City, NY69 проучвания
- Boston, MA61 проучвания
- Los Angeles, CA50 проучвания
- Nashville, TN49 проучвания
- Arlington, VA46 проучвания
- Philadelphia, PA44 проучвания
- Columbus, OH39 проучвания
- St. Louis, MO38 проучвания
- Chicago, IL36 проучвания
- San Antonio, TX31 проучвания
- Cleveland, OH30 проучвания
Други проучвания в Miami
- Рак на гърдата42 проучвания
- Рак (всички видове)36 проучвания
- Рак на белия дроб с недребноклетъчен тип31 проучвания
- Рак на простатата27 проучвания
- Затлъстяване27 проучвания
- Остра миелоидна левкемия24 проучвания
- Метастатичен рак23 проучвания
- Наднормено тегло23 проучвания
- Язвенен колит21 проучвания
- Множествен миелом21 проучвания
- Болест на Алцхаймер20 проучвания
- Рак на белия дроб20 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.